Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 50090-7080 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

equation - equation

This is a formula for calculating cLer using the patient's age (in years) and weight (in kg), as well as serum creatinine levels (in mg/dL). It multiplies the age by weight and then by 72 times the serum creatinine for female patients. The result of this calculation can help assess renal function or determine appropriate medication dosages.*

fig-1 - fig 1

fig-2 - fig 2

This text provides information about the Mean Pain Score study conducted with placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day during a 3-week dose titration period followed by a 4-week fixed dose period. The study tracks pain scores over 7 weeks.*

fig-3 - fig 3

This text provides data on the proportion of responders in controlled studies of postherpetic neuralgia (PHN), where patients experienced a reduction in pain score of over 50%. The study compared the effectiveness of different dosages of GBP (gabapentin) with a placebo (PBO). Study 1 showed a response rate of 29% for GBP 300, while Study 2 showed a response rate of 31% for GBP 1800 and 24% for GBP 2400.*

fig-4 - fig 4

Label Image - lbl500907080

This is a description for a health supplement called "SharsenTIN 600 MG" which comes in a bottle containing 90 tablets. It is recommended to store it at 68-77 degrees Fahrenheit.*

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.